Clinical Characteristics of COVID-19: Use of Steroids in Mostly Unvaccinated COVID-19 Patients Before the Omicron Variant

BACKGROUND: Glucocorticoids are one of the current standard agents for moderate to severe coronavirus disease 2019 (COVID-19) treatment based on the RECOVERY trial. Data on the real clinical application of steroids for COVID-19 are scarce and will help guide the optimal use of steroids. We described...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Sang-Min, Ham, Sin Young, Suh, Hyeon Jeong, Lee, Eunyoung, Park, Sang-Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313976/
https://www.ncbi.nlm.nih.gov/pubmed/35880504
http://dx.doi.org/10.3346/jkms.2022.37.e228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313976/
https://www.ncbi.nlm.nih.gov/pubmed/35880504
http://dx.doi.org/10.3346/jkms.2022.37.e228

Ejemplares similares